Medicare Advantage Offers Digital Therapeutics to Improve Pain Management
New York, Friday, 31 January 2025.
Medicare Advantage members in Massachusetts and Arizona can now manage pain through Kaia Health’s digital therapeutics, showcasing promising outcomes like a 73% reduction in chronic pain.
Transformative Digital Health Partnership
On January 29, 2025, eternalHealth and Kaia Health announced a groundbreaking partnership that brings advanced digital therapeutics to Medicare Advantage members [1][3]. This collaboration marks a significant advancement in healthcare delivery, with clinical trials demonstrating remarkable outcomes including a 73% reduction in chronic pain and a 39% improvement in sleep quality among users [1]. The partnership leverages Kaia Health’s extensive experience, validated through 20 clinical trials, to deliver personalized care solutions directly through smartphones and tablets [1].
Real-World Impact and Accessibility
The implementation of these digital solutions has already shown promising results in real-world applications. Larry Butler, Sr. Director of Financial Underwriting at BCBS, reported significant improvements in core strength and pain reduction after four months of using the Kaia program [1]. The platform’s reach is substantial, with Kaia Health currently serving nearly 65 million lives globally through their specialized digital therapeutics for musculoskeletal conditions and COPD [1][3].
Geographic Expansion and Future Outlook
Based in Boston, eternalHealth’s strategic focus on Massachusetts and Arizona positions this partnership to immediately impact thousands of Medicare Advantage members in these regions [1]. Pooja Ika, Founder & CEO of eternalHealth, emphasized that this collaboration represents a crucial step forward in delivering innovative, high-quality care to members [1]. The partnership demonstrates Kaia Health’s continued expansion in the Medicare Advantage space, with the company actively seeking additional MA plans to enhance their offerings [3].